BIO Launches National Campaign Highlighting Patient Stories Behind Biotechnology Breakthroughs
Hand-rolled, kettle-boiled, baked to perfection. Worth every minute at the bakery.
Summary
The Biotechnology Innovation Organization (BIO) has launched a national campaign called "The Fight of Our Lives" to highlight the human stories behind biotechnology breakthroughs. The campaign focuses on patients whose lives depend on biotech innovations and the scientists working to make them possible, coinciding with the 50th anniversary of America's biotechnology industry. It aims to showcase the human faces of biotech as the industry continues to lead in life-saving innovation amid increasing global challenges.
Key quotes
· 2 pulledThe Fight of Our Lives showcases the human faces of biotech as the industry continues to lead the world in life-saving innovation.
The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them, and the scientists working to make them possible.
You might also wanna read
Biohub launches $500M Virtual Biology Initiative to build predictive models of human cells
Biohub has announced the Virtual Biology Initiative, a $500 million, five-year global effort to develop technologies and multi-modal dataset
Personal Mission to Accelerate Brain Tumor Research Using AI Scientists
A personal narrative about a man whose girlfriend was diagnosed with a brain tumor, leading him to launch an experiment using AI-Scientists
Nucleo launches automated cancer diagnostics platform on Product Hunt
Nucleo is launching an automated cancer diagnostics platform on Product Hunt. It claims to be the first to apply world model AI technology t
BIOS AI Platform for Biomedical Research Ranks #1 on BixBench Benchmark
BIOS is an AI-powered scientific research platform that ranked #1 on BixBench for biological data analysis. The system offers flexible resea

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t

Goldman Sachs Report Questions Financial Sustainability of Curative Gene Therapies
Goldman Sachs analysts question whether curing patients is a sustainable business model for biotech companies, particularly those developing
